SIRION Biotech, now part of Revvity (acquired), was a German company founded in 2005 specializing in viral vector development and manufacturing for cell and gene therapy research and preclinical development. Their expertise includes adeno-associated viruses (AAV), lentiviruses, and adenoviruses, plus the LentiBOOST transduction enhancer technology. However, SIRION Biotech's services are now fully integrated into Revvity's gene delivery division. They serve biotech and pharma companies with viral vector R&D services and preclinical-stage manufacturing, not as an independent CDMO offering clinical/commercial GMP manufacturing under contract. Their work is research-services focused.
viral vector development, AAV engineering, lentiviral transduction (LentiBOOST), adenovirus manufacturing, gene therapy research services
2 sites worldwide
No certifications on file yet.
No reviews available yet.
No documents available.